Stories with tag: "Cancer Podcasts"
Cancer
The Impact and Promise of the Rush Cell Therapy Lab at RUSH MD Anderson Cancer Center With Mahzad Akbarpour, PhD
Mahzad Akbarpour, PhD, is director of the Rush Cell Therapy Lab at RUSH MD Anderson Cancer Center and is an assistant professor of Internal Medicine in the Division of Hematology, Oncology and Cell Therapy.
Cancer
Coordinated, Interdisciplinary Care in the Rush Spine Tumor Clinic With John O’Toole, MD, and Ken Tatebe, MD
John O’Toole, MD, MS, is a neurosurgeon and the co-director of neurosciences service line at Rush, as well as the co-director of the Coleman Foundation Comprehensive Spine Tumor Clinic.
Ken Tatebe, MD, is the clinical director of stereotactic radiosurgery, the neuro-oncology research director and is a radiation oncologist at Rush.
Ken Tatebe, MD, is the clinical director of stereotactic radiosurgery, the neuro-oncology research director and is a radiation oncologist at Rush.
Cancer
High-Risk Colorectal Cancer Surveillance and the Use of GI Genius With Salina Lee, MD
In this episode, Salina Lee, MD, a gastroenterologist at RUSH University Medical Center, will discuss how the detection and removal of adenomas is key to helping gastroenterologists prevent patients from developing colorectal cancer. Additionally, she will profile several colorectal cancer screening tools, as well as the latest advancements in colonoscopy, including the use of GI Genius that helps to produce higher adenoma detection rates.
Cancer
Frontline Treatments for Non-muscle Invasive and Invasive Bladder Cancer with Gary Steinberg, MD
Gary Steinberg, MD, is a urologist at RUSH and a national authority in the surgical treatment of bladder cancer and continent urinary tract reconstruction. He is a recognized expert in translational bladder cancer research and has made significant contributions to the understanding of both non-muscle invasive and invasive bladder cancer.
Cancer
Novel Organoid Drug Testing and Pregnancy-Associated Breast Cancer Care at RUSH with Jessica Slostad, MD
Jessica Slostad, MD, is an assistant professor of Medicine in the Division of Hematology, Oncology and Cellular Therapy at RUSH and specializes in breast cancer management. Her research interests include clinical and translational research with a focus on precision oncology and organoid technology.
Cancer
Genetic Profiling of Non-Small Cell Lung Cancer at RUSH with Mary Jo Fidler, MD
Mary Jo Fidler, MD, is a thoracic oncologist and professor of Internal Medicine at RUSH University Medical Center. She is the Medical Oncology Section Chief in the RUSH Cancer Center and is the national principal investigator for the ADAURA trial, which is studying the effects of postoperative Osimertinib in resected EGFR+ lung cancer patients.
Cancer
Critical Limb Ischemia Management and Limb Salvage with Kumar Madassery, MD
Kumar Madassery, MD, the director of the Peripheral Vascular Interventions and Critical Limb Ischemia Program in the RUSH University System for Health, discusses limb ischemia management and limb salvage.
Cancer
Physiatry Care and Cancer Rehabilitation in the RUSH Cancer Center with Obada Obaisi, MD
Obada Obaisi, MD, is an assistant professor in the RUSH Department of Physical Medicine and Rehabilitation and is the director of cancer rehabilitation at RUSH University Medical Center. Obaisi shares how RUSH is one of a small number of hospitals offering dedicated physical medicine and rehabilitation care for its cancer patients.
Cancer
RUSH’s Advanced Diagnostic and Treatment Options for Prostate Cancer with Edward Cherullo, MD
Edward Cherullo, MD, is a urologist and the chief of the Department of Urology at RUSH University Medical Center. Under his leadership, Cherullo has expanded the department’s efforts to provide comprehensive subspecialty care that incorporates the latest minimally invasive technology.
Brain Health & Conditions
The Rush Center for Skull Base and Pituitary Surgery with Pete Batra, MD
Pete Batra, MD, the Chair of the Department of Otorhinolaryngology – Head and Neck Surgery at Rush University Medical Center, highlights Rush’s unparalleled expertise, its use of leading-edge treatments and how it’s developing novel therapies for rare types of cancers.